Celesio takeover of Sainsbury pharmacies approved

Celesio has been given the go-ahead to proceed with its £125m acquisition of Sainsbury's pharmacy business.

The Competition and Markets Authority has approved Celesio's takeover of 281 Sainsbury pharmacies – 277 in store and four in hospitals – all of which will be rebranded as Lloydspharmacy. Sainsbury's pharmacy staff will transfer to Lloydspharmacy under TUPE.

The CMA has identified 12 local geographic areas where the acquisition of Sainsbury's pharmacies may be expected to result in a lessening of competition. As a result, Celesio will be "working over the coming months to remedy the situation and ensure that LloydsPharmacy colleagues in the affected areas are supported during the transition". This will involve selling some pharmacies.

Cormac Tobin (pictured), managing director of LloydsPharmacy and Celesio UK, said: “Sainsbury’s is a leading UK retailer, which has created an attractive pharmacy business. As a specialist pharmacy operator we can build on this strong foundation to offer Sainsbury’s customers a more enhanced health offering. We also gain access to new customer groups and to new locations where LloydsPharmacy’s physical bricks and mortar presence is not currently as strong." 


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.